Pharmacokinetic and Pharmacodynamic Properties of Meropenem

10.1086/516284

10.1038/nrmicro862

10.1093/jac/39.6.677

Forrest A, 1993, Antimicrob Agents Chemother, 37, 1073, 10.1128/AAC.37.5.1073

Hatano K, 1994, Chemotherapy, 40, 1, 10.1159/000239162

10.1086/514622

10.1592/phco.26.9.1320

MERREM I.V. (meropenem for injection) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals, 2007.

Hutchison M, 1995, J Antimicrob Chemother, 36, 43, 10.1093/jac/36.suppl_A.43

Condon RE, 1997, Clin Infect Dis, 24, S181, 10.1093/clinids/24.Supplement_2.S181

Bedikian A, 1994, Antimicrob Agents Chemother, 38, 151, 10.1128/AAC.38.1.151

Gall S, 1997, Clin Infect Dis, 24, S178, 10.1093/clinids/24.Supplement_2.S178

Byl B, 1999, Antimicrob Agents Chemother, 43, 681, 10.1128/AAC.43.3.681

10.1016/j.ijantimicag.2005.08.015

Newsom SWB, 1995, J Antimicrob Chemother, 36, 57, 10.1093/jac/36.suppl_A.57

Wise R, 1990, Antimicrob Agents Chemother, 34, 1515, 10.1128/AAC.34.8.1515

10.1128/AAC.47.5.1771-1773.2003

Leroy A, 1992, Antimicrob Agents Chemother, 36, 2794, 10.1128/AAC.36.12.2794

10.1007/BF00314864

Chimata M, 1993, Antimicrob Agents Chemother, 37, 229, 10.1128/AAC.37.2.229

Christensson BA, 1992, Antimicrob Agents Chemother, 36, 1532, 10.1128/AAC.36.7.1532

Thalhammer F, 1998, Antimicrob Agents Chemother, 42, 2417, 10.1128/AAC.42.9.2417

10.1016/S0009-9236(99)70121-9

Krueger WA, 1998, Antimicrob Agents Chemother, 42, 2421, 10.1128/AAC.42.9.2421

10.1159/000086598

Thyrum PT, 1997, Clin Infect Dis, 24, S184, 10.1093/clinids/24.Supplement_2.S184

Ljungberg B, 1992, Antimicrob Agents Chemother, 36, 1437, 10.1128/AAC.36.7.1437

Blumer JL, 1995, Antimicrob Agents Chemother, 39, 1721, 10.1128/AAC.39.8.1721

Parker EM, 1995, J Antimicrob Chemother, 36, 63, 10.1093/jac/36.suppl_A.63

10.1177/0091270005283283

Craig WA, Ebert S, Watanabe Y. Differences in time above MIC ( ) required for efficacy of beta-lactams in animal infection models [abstract 86]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993.

10.1016/j.diagmicrobio.2006.06.014

10.1016/S0149-2918(04)80001-8

10.1128/AAC.49.1.276-280.2005

10.1128/AAC.00752-06

10.1016/j.diagmicrobio.2005.10.004

10.1128/AAC.48.7.2464-2470.2004

10.1093/jac/dkh511

10.1016/j.diagmicrobio.2004.03.003

10.2165/00148581-200608020-00005

10.1089/sur.2005.6.419

10.1089/sur.2005.6.297

10.1016/j.clinthera.2005.07.004

10.1097/01.CCM.0000181528.88571.9B

10.1016/j.ijantimicag.2006.02.018

Ariano RE, 2005, Ann Pharmacother, 39, 32, 10.1345/aph.1E271

10.1128/AAC.00294-06

10.1177/0091270006291035

10.1177/0091270003257225

10.1128/AAC.49.1.461-463.2005

10.1093/jac/dkg378

10.1128/AAC.49.4.1337-1339.2005

10.1128/AAC.49.5.1881-1889.2005

10.1093/jac/43.4.523

10.1016/j.clinthera.2004.11.009

10.2165/00003495-200666010-00001

10.1128/AAC.49.12.4920-4927.2005